PULMONX CORPORATION Additional Paid in Capital, Common Stock
PULMONX CORPORATION (LUNG) had Additional Paid in Capital, Common Stock of $582.40 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-04
- 2026-06-30: Additional Paid in Capital, Common Stock $582.40M.
- 2026-03-31: Additional Paid in Capital, Common Stock $578.76M.
- 2025-12-31: Additional Paid in Capital, Common Stock $573.27M.
- 2025-09-30: Additional Paid in Capital, Common Stock $568.89M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $582.40M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $578.76M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $573.27M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $568.89M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $563.59M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $557.43M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $551.21M 10-K · filed 2026-03-10 |
| 2024-09-30 | $545.73M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $539.41M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $533.41M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $526.80M 10-K · filed 2025-02-25 |
| 2023-09-30 | $521.03M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $514.33M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $508.25M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $502.71M 10-K · filed 2024-02-27 |
| 2022-09-30 | $498.08M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $492.65M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $487.89M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $482.88M 10-K · filed 2023-03-01 |
| 2021-09-30 | $479.64M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $475.56M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $469.95M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $467.15M 10-K · filed 2022-03-01 |
| 2020-09-30 | $24.90M 10-Q · filed 2020-11-13 |
| 2019-12-31 | $21.75M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |